Correlation of O-6-Methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity Article

Hegi, Monika E, Liu, Lili, Herman, James G et al. (2008). Correlation of O-6-Methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity . JOURNAL OF CLINICAL ONCOLOGY, 26(25), 4189-4199. 10.1200/JCO.2007.11.5964

Open Access International Collaboration

cited authors

  • Hegi, Monika E; Liu, Lili; Herman, James G; Stupp, Roger; Wick, Wolfgang; Weller, Michael; Mehta, Minesh P; Gilbert, Mark R

sustainable development goals

authors

publication date

  • September 1, 2008

webpage

published in

keywords

  • BASE EXCISION-REPAIR
  • CARMUSTINE PLUS O-6-BENZYLGUANINE
  • DNA-REPAIR
  • Life Sciences & Biomedicine
  • MISMATCH REPAIR
  • O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE ACTIVITY
  • O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE
  • Oncology
  • PHASE-I TRIAL
  • PROGNOSTIC-SIGNIFICANCE
  • PROGRESSIVE MALIGNANT GLIOMA
  • Science & Technology
  • THERAPEUTIC IMPLICATIONS

Digital Object Identifier (DOI)

publisher

  • AMER SOC CLINICAL ONCOLOGY

start page

  • 4189

end page

  • 4199

volume

  • 26

issue

  • 25